Ypsomed Holding AG (SWX:YPSN)

Market Cap	4.50B
Revenue (ttm)	617.07M
Net Income (ttm)	74.39M
Shares Out	13.65M
EPS (ttm)	5.45
PE Ratio	60.46
Forward PE	32.85
Dividend	2.00 (0.62%)
Ex-Dividend Date	Jul 1, 2024

Volume	1,363
Average Volume	18,963
Open	330.50
Previous Close	329.50
Day's Range	325.50 - 330.50
52-Week Range	261.00 - 439.00
Beta	1.12
RSI	49.14
Earnings Date	May 21, 2025

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1984
• Employees: 2,296
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: YPSN

Financial Performance

In 2023, Ypsomed Holding AG's revenue was 548.46 million, an increase of 10.25% compared to the previous year's 497.46 million. Earnings were 78.37 million, an increase of 52.83%.